Login / Signup
Suggested treatment of serious complications to COVID-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme.
Fredrik Kahn
Oonagh Shannon
Lars Björck
Published in:
Journal of thrombosis and haemostasis : JTH (2021)
Keyphrases
</>
coronavirus disease
sars cov
risk factors
replacement therapy